Evidence map›Paper›PMID 34848750›Full record

ArticleScientific reports2021

A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.

Grace MacDonald, Andrea Sitlinger, Michael A Deal, Erik D Hanson, Stephanie Ferraro, Carl F Pieper, J Brice Weinberg, Danielle M Brander, David B Bartlett

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Rates of compliance and adherence to high-intensity interval training: a systematic review and Meta-analyses.The international journal of behavioral nutrition and physical activity · 2023
    Pooled it
  4. Trial
  5. Exercise therapy in cancer prevention and treatment.Nature reviews. Clinical oncology · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Grace MacDonaldDivision of Medical Oncology, Duke University School of Medicine, Durham, NC, USA.
Andrea SitlingerHematologic Malignancies and Cellular Therapies, Duke University School of Medicine, Durham, NC, USA.
Michael A DealDivision of Medical Oncology, Duke University School of Medicine, Durham, NC, USA.
Erik D HansonDepartment of Exercise and Sport Science, University of North Carolina, Chapel Hill, NC, USA.
Stephanie FerraroDepartment of Exercise and Sport Science, University of North Carolina, Chapel Hill, NC, USA.
Carl F PieperDuke University Aging Center, Duke University School of Medicine, Durham, NC, USA.
J Brice WeinbergDivision of Hematology, Duke University School of Medicine and VA Medical Center, Durham, NC, USA.
Danielle M BranderHematologic Malignancies and Cellular Therapies, Duke University School of Medicine, Durham, NC, USA.
David B BartlettDivision of Medical Oncology, Duke University School of Medicine, Durham, NC, USA. david.bartlett@duke.edu.
Duke University · USUniversity of North Carolina at Chapel Hill · USDuke Medical Center · USUniversity of Surrey · GB

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Virginia B Kraus · 2006 to 2026
$24.6M
TRANSFUSION MEDICINE AND RELATED AREAST32HL007057 · NHLBI · DUKE UNIVERSITY · PI Gowthami M Arepally · 1985 to 2026
$10.6M
NHLBI NIH HHS T32 HL007057NIA NIH HHS P30 AG028716
6 · The paper itself

Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the USA, affecting predominantly older adults. CLL is characterized by low physical fitness, reduced immunity, and increased risk of secondary malignancies and infections. One approach to improving CLL patients' physical fitness and immune functions may be participation in a structured exercise program. The aims of this pilot study were to examine physical and immunological changes, and feasibility of a 12-week high-intensity interval training (HIIT) combined with muscle endurance-based resistance training on older adults with treatment naïve CLL. We enrolled eighteen participants with CLL aged 64.9 ± 9.1 years and assigned them to groups depending on distance lived from our fitness center. Ten participants (4 M/6F) completed HIIT and six participants (4 M/2F) completed a non-exercising control group (Controls). HIIT consisted of three 30-min treadmill sessions/week plus two concurrent 30-min strength training sessions/week. Physical and immunological outcomes included aerobic capacity, muscle strength and endurance, and natural killer (NK) cell recognition and killing of tumor cells. We confirmed feasibility if > 70% of HIIT participants completed > 75% of prescribed sessions and prescribed minutes, and if > 80% of high-intensity intervals were at a heart rate corresponding to at least 80% of peak aerobic capacity (VO

Indexed as

AgedBody CompositionCardiorespiratory FitnessExerciseExercise TherapyExercise ToleranceFemaleHeart RateHigh-Intensity Interval TrainingHumansK562 CellsKiller Cells, NaturalLeukemia, Lymphocytic, Chronic, B-CellLeukocytes, MononuclearMaleMiddle Aged

Identifiers

PMID34848750
PMCPMC8633014
OpenAlexW3215714718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.